Skip to main content

Animations

MJFF Publications

6421 - 6430 of 6433 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2020
  • 2015
  • 2024
  • 2024
  • 2021
  • 2021
  • 2017
  • 2018
  • Summary Details
    OPEN
    Title: Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra119.011650
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Biallelic BORCS8 variants cause an infantile-onset neurodegenerative disorder with altered lysosome dynamics
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain, public-domain
    DOI - Digital Object Identifier: 10.1093/brain/awad427
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Falls Risk in Relation to Activity Exposure in High-Risk Older Adults
    Journal Name: The Journals of Gerontology: Series A
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/gerona/glaa007
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Is the MC1R variant p.R160W associated with Parkinson's?
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24527
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699.3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2356490
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00182-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Variable number tandem repeats – Their emerging role in sickness and health
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1177/15353702211003511
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 85
  • Summary Details
    OPEN
    Title: PP1 Phosphatase Complexes: Undruggable No Longer
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.